S&P 500   3,977.74 (+0.17%)
DOW   32,453.99 (+0.67%)
QQQ   309.01 (-0.60%)
AAPL   158.49 (-1.10%)
MSFT   276.70 (-1.38%)
META   202.32 (-1.79%)
GOOGL   102.69 (-2.61%)
AMZN   97.42 (-0.72%)
TSLA   191.56 (+0.60%)
NVDA   264.84 (-1.10%)
NIO   8.92 (-1.65%)
BABA   85.65 (-1.44%)
AMD   95.98 (-2.01%)
T   18.86 (+1.34%)
F   11.53 (+0.17%)
MU   59.69 (-2.40%)
CGC   1.90 (-0.26%)
GE   93.12 (+1.92%)
DIS   94.90 (+0.87%)
AMC   4.36 (-2.46%)
PYPL   73.25 (-0.85%)
PFE   40.34 (-0.12%)
NFLX   327.73 (-0.20%)
S&P 500   3,977.74 (+0.17%)
DOW   32,453.99 (+0.67%)
QQQ   309.01 (-0.60%)
AAPL   158.49 (-1.10%)
MSFT   276.70 (-1.38%)
META   202.32 (-1.79%)
GOOGL   102.69 (-2.61%)
AMZN   97.42 (-0.72%)
TSLA   191.56 (+0.60%)
NVDA   264.84 (-1.10%)
NIO   8.92 (-1.65%)
BABA   85.65 (-1.44%)
AMD   95.98 (-2.01%)
T   18.86 (+1.34%)
F   11.53 (+0.17%)
MU   59.69 (-2.40%)
CGC   1.90 (-0.26%)
GE   93.12 (+1.92%)
DIS   94.90 (+0.87%)
AMC   4.36 (-2.46%)
PYPL   73.25 (-0.85%)
PFE   40.34 (-0.12%)
NFLX   327.73 (-0.20%)
S&P 500   3,977.74 (+0.17%)
DOW   32,453.99 (+0.67%)
QQQ   309.01 (-0.60%)
AAPL   158.49 (-1.10%)
MSFT   276.70 (-1.38%)
META   202.32 (-1.79%)
GOOGL   102.69 (-2.61%)
AMZN   97.42 (-0.72%)
TSLA   191.56 (+0.60%)
NVDA   264.84 (-1.10%)
NIO   8.92 (-1.65%)
BABA   85.65 (-1.44%)
AMD   95.98 (-2.01%)
T   18.86 (+1.34%)
F   11.53 (+0.17%)
MU   59.69 (-2.40%)
CGC   1.90 (-0.26%)
GE   93.12 (+1.92%)
DIS   94.90 (+0.87%)
AMC   4.36 (-2.46%)
PYPL   73.25 (-0.85%)
PFE   40.34 (-0.12%)
NFLX   327.73 (-0.20%)
S&P 500   3,977.74 (+0.17%)
DOW   32,453.99 (+0.67%)
QQQ   309.01 (-0.60%)
AAPL   158.49 (-1.10%)
MSFT   276.70 (-1.38%)
META   202.32 (-1.79%)
GOOGL   102.69 (-2.61%)
AMZN   97.42 (-0.72%)
TSLA   191.56 (+0.60%)
NVDA   264.84 (-1.10%)
NIO   8.92 (-1.65%)
BABA   85.65 (-1.44%)
AMD   95.98 (-2.01%)
T   18.86 (+1.34%)
F   11.53 (+0.17%)
MU   59.69 (-2.40%)
CGC   1.90 (-0.26%)
GE   93.12 (+1.92%)
DIS   94.90 (+0.87%)
AMC   4.36 (-2.46%)
PYPL   73.25 (-0.85%)
PFE   40.34 (-0.12%)
NFLX   327.73 (-0.20%)
TSE:CPH

Cipher Pharmaceuticals - CPH Price Target & Analyst Ratings

C$3.28
-0.07 (-2.09%)
(As of 03/27/2023 12:18 PM ET)
Add
Compare
Today's Range
C$3.28
▼
C$3.41
50-Day Range
C$3.34
▼
C$3.87
52-Week Range
C$2.00
▼
C$4.07
Volume
7,409 shs
Average Volume
13,209 shs
Market Capitalization
C$82.26 million
P/E Ratio
7.13
Dividend Yield
N/A
Price Target
N/A

Cipher Pharmaceuticals Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 2 Analyst Ratings

Consensus Analyst Price Target

N/A

TypeCurrent
3/27/22 to 3/27/23		1 Month Ago
2/25/22 to 2/25/23		3 Months Ago
12/27/21 to 12/27/22		1 Year Ago
3/27/21 to 3/27/22
Consensus Rating
Buy
Buy
Buy
N/A
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
 N/A
Buy
2 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
 N/A
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
 N/A
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
 N/A
Consensus Price TargetN/AN/AN/AN/A
Predicted UpsideN/AN/AN/AN/A
Get Cipher Pharmaceuticals Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CPH and its competitors with MarketBeat's FREE daily newsletter.

CPH Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CPH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cipher Pharmaceuticals Stock vs. The Competition

TypeCipher PharmaceuticalsMedical Companies
Consensus Rating Score
3.00
2.64
Consensus RatingBuyBuy
News Sentiment RatingNeutral News
Positive News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/17/2023Leede Jones Gab
Subscribe to MarketBeat All Access for the recommendation accuracy rating		D. Loe
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingBuy
5/13/2022Echelon Wealth Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating		D. Loe
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingBuy
5/8/2020Bloom Burton
Subscribe to MarketBeat All Access for the recommendation accuracy rating		D. Martin
Subscribe to MarketBeat All Access for the recommendation accuracy rating		UpgradeHold ➝ Accumulate
(Data available from 3/27/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












CPH Price Target - Frequently Asked Questions

What is Cipher Pharmaceuticals's consensus rating?

According to the issued ratings of 2 analysts in the last year, the consensus rating for Cipher Pharmaceuticals stock is Buy based on the current 2 buy ratings for CPHthe . Learn more on CPH's analyst rating history.

Do Wall Street analysts like Cipher Pharmaceuticals more than its competitors?

Analysts like Cipher Pharmaceuticals more than other Medical companies. The consensus rating score for Cipher Pharmaceuticals is 3.00 while the average consensus rating score for medical companies is 2.64. Learn more on how CPH compares to other companies.

What analysts cover Cipher Pharmaceuticals?

Cipher Pharmaceuticals has been rated by Leede Jones Gab in the past 90 days.


Stock Ratings Reports and Tools

Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
Ratings for Popular Stocks:
This page (TSE:CPH) was last updated on 3/27/2023 by MarketBeat.com Staff